In this report, the EMEA Gastrointestinal OTC Drugs market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Gastrointestinal OTC Drugs for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.
EMEA Gastrointestinal OTC Drugs market competition by top manufacturers/players, with Gastrointestinal OTC Drugs sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
Bayer
GlaxoSmithKline
Johnson & Johnson
Pfizer
Perrigo
Abbott
C.B. Fleet
Purdue Pharma
Teva Pharmaceutical
Sanofi
Boehringer Ingelheim
Xiuzheng Pharmaceutical Group
China Resources Sanjiu Medical & Pharmaceutical
Harbin Pharmaceutical Group
JZJT
Tongrentang (TRT)
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Capsule
Tablet
Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
EMEA (Europe, Middle East and Africa) Gastrointestinal OTC Drugs Market Report 2017
1 Gastrointestinal OTC Drugs Overview
1.1 Product Overview and Scope of Gastrointestinal OTC Drugs
1.2 Classification of Gastrointestinal OTC Drugs
1.2.1 EMEA Gastrointestinal OTC Drugs Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Gastrointestinal OTC Drugs Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Capsule
1.2.4 Tablet
1.2.5 Others
1.3 EMEA Gastrointestinal OTC Drugs Market by Application/End Users
1.3.1 EMEA Gastrointestinal OTC Drugs Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Online Pharmacy
1.4 EMEA Gastrointestinal OTC Drugs Market by Region
1.4.1 EMEA Gastrointestinal OTC Drugs Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Gastrointestinal OTC Drugs (2012-2022)
1.5.1 EMEA Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2022)
1.5.2 EMEA Gastrointestinal OTC Drugs Revenue and Growth Rate (2012-2022)
2 EMEA Gastrointestinal OTC Drugs Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Gastrointestinal OTC Drugs Market Competition by Players/Manufacturers
2.1.1 EMEA Gastrointestinal OTC Drugs Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Gastrointestinal OTC Drugs Revenue and Share by Players (2012-2017)
2.1.3 EMEA Gastrointestinal OTC Drugs Sale Price by Players (2012-2017)
2.2 EMEA Gastrointestinal OTC Drugs (Volume and Value) by Type/Product Category
2.2.1 EMEA Gastrointestinal OTC Drugs Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Gastrointestinal OTC Drugs Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Gastrointestinal OTC Drugs Sale Price by Type (2012-2017)
2.3 EMEA Gastrointestinal OTC Drugs (Volume) by Application
2.4 EMEA Gastrointestinal OTC Drugs (Volume and Value) by Region
2.4.1 EMEA Gastrointestinal OTC Drugs Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Gastrointestinal OTC Drugs Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Gastrointestinal OTC Drugs Sales Price by Region (2012-2017)
3 Europe Gastrointestinal OTC Drugs (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Gastrointestinal OTC Drugs Sales and Value (2012-2017)
3.1.1 Europe Gastrointestinal OTC Drugs Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Gastrointestinal OTC Drugs Revenue and Growth Rate (2012-2017)
3.2 Europe Gastrointestinal OTC Drugs Sales and Market Share by Type
3.3 Europe Gastrointestinal OTC Drugs Sales and Market Share by Application
3.4 Europe Gastrointestinal OTC Drugs Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Gastrointestinal OTC Drugs Sales Volume by Countries (2012-2017)
3.4.2 Europe Gastrointestinal OTC Drugs Revenue by Countries (2012-2017)
3.4.3 Germany Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
3.4.4 France Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
3.4.5 UK Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
3.4.6 Russia Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
3.4.7 Italy Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
3.4.8 Benelux Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
4 Middle East Gastrointestinal OTC Drugs (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Gastrointestinal OTC Drugs Sales and Value (2012-2017)
4.1.1 Middle East Gastrointestinal OTC Drugs Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Gastrointestinal OTC Drugs Revenue and Growth Rate (2012-2017)
4.2 Middle East Gastrointestinal OTC Drugs Sales and Market Share by Type
4.3 Middle East Gastrointestinal OTC Drugs Sales and Market Share by Application
4.4 Middle East Gastrointestinal OTC Drugs Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Gastrointestinal OTC Drugs Sales Volume by Countries (2012-2017)
4.4.2 Middle East Gastrointestinal OTC Drugs Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
4.4.4 Israel Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
4.4.5 UAE Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
4.4.6 Iran Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
5 Africa Gastrointestinal OTC Drugs (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Gastrointestinal OTC Drugs Sales and Value (2012-2017)
5.1.1 Africa Gastrointestinal OTC Drugs Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Gastrointestinal OTC Drugs Revenue and Growth Rate (2012-2017)
5.2 Africa Gastrointestinal OTC Drugs Sales and Market Share by Type
5.3 Africa Gastrointestinal OTC Drugs Sales and Market Share by Application
5.4 Africa Gastrointestinal OTC Drugs Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Gastrointestinal OTC Drugs Sales Volume by Countries (2012-2017)
5.4.2 Africa Gastrointestinal OTC Drugs Revenue by Countries (2012-2017)
5.4.3 South Africa Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
5.4.5 Egypt Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
5.4.6 Algeria Gastrointestinal OTC Drugs Sales and Growth Rate (2012-2017)
6 EMEA Gastrointestinal OTC Drugs Manufacturers/Players Profiles and Sales Data
6.1 Bayer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Bayer Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 GlaxoSmithKline Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Johnson & Johnson
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Johnson & Johnson Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Pfizer
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Pfizer Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Perrigo
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Perrigo Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Abbott
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Abbott Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 C.B. Fleet
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 C.B. Fleet Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Purdue Pharma
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Purdue Pharma Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Teva Pharmaceutical
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Teva Pharmaceutical Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Sanofi
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Gastrointestinal OTC Drugs Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Sanofi Gastrointestinal OTC Drugs Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 Boehringer Ingelheim
6.12 Xiuzheng Pharmaceutical Group
6.13 China Resources Sanjiu Medical & Pharmaceutical
6.14 Harbin Pharmaceutical Group
6.15 JZJT
6.16 Tongrentang (TRT)
7 Gastrointestinal OTC Drugs Manufacturing Cost Analysis
7.1 Gastrointestinal OTC Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Gastrointestinal OTC Drugs
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Gastrointestinal OTC Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2016
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 EMEA Gastrointestinal OTC Drugs Market Forecast (2017-2022)
11.1 EMEA Gastrointestinal OTC Drugs Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Gastrointestinal OTC Drugs Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Gastrointestinal OTC Drugs Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Gastrointestinal OTC Drugs Price and Trend Forecast (2017-2022)
11.2 EMEA Gastrointestinal OTC Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Gastrointestinal OTC Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Gastrointestinal OTC Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Gastrointestinal OTC Drugs Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Gastrointestinal OTC Drugs Sales Forecast by Type (2017-2022)
11.7 EMEA Gastrointestinal OTC Drugs Sales Forecast by Application (2017-2022)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
List of Tables and Figures
Figure Product Picture of Gastrointestinal OTC Drugs
Figure EMEA Gastrointestinal OTC Drugs Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Gastrointestinal OTC Drugs Sales Volume Market Share by Type (Product Category) in 2016
Figure Capsule Product Picture
Figure Tablet Product Picture
Figure Others Product Picture
Figure EMEA Gastrointestinal OTC Drugs Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Gastrointestinal OTC Drugs by Application in 2016
Figure Hospital Pharmacy Examples
Table Key Downstream Customer in Hospital Pharmacy
Figure Retail Pharmacy Examples
Table Key Downstream Customer in Retail Pharmacy
Figure Online Pharmacy Examples
Table Key Downstream Customer in Online Pharmacy
Figure EMEA Gastrointestinal OTC Drugs Market Size (Million USD) by Region (2012-2022)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Gastrointestinal OTC Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Gastrointestinal OTC Drugs Revenue (Million USD) Status and Forecast by Countries
Figure Africa Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Gastrointestinal OTC Drugs Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Gastrointestinal OTC Drugs Sales Volume and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Gastrointestinal OTC Drugs Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales Share by Players (2012-2017)
Figure 2016 Gastrointestinal OTC Drugs Sales Share by Players
Figure 2017 Gastrointestinal OTC Drugs Sales Share by Players
Figure EMEA Gastrointestinal OTC Drugs Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Revenue (Million USD) by Players (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Revenue Share by Players (2012-2017)
Table 2016 EMEA Gastrointestinal OTC Drugs Revenue Share by Players
Table 2017 EMEA Gastrointestinal OTC Drugs Revenue Share by Players
Table EMEA Gastrointestinal OTC Drugs Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales Share by Type (2012-2017)
Figure Sales Market Share of Gastrointestinal OTC Drugs by Type (2012-2017)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share by Type (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Gastrointestinal OTC Drugs by Type in 2016
Table EMEA Gastrointestinal OTC Drugs Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales Share by Application (2012-2017)
Figure Sales Market Share of Gastrointestinal OTC Drugs by Application (2012-2017)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share by Application in 2016
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Sales Share by Region (2012-2017)
Figure Sales Market Share of Gastrointestinal OTC Drugs by Region (2012-2017)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share in 2016
Table EMEA Gastrointestinal OTC Drugs Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Gastrointestinal OTC Drugs Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Gastrointestinal OTC Drugs by Region (2012-2017)
Figure EMEA Gastrointestinal OTC Drugs Revenue Market Share Regions in 2016
Table EMEA Gastrointestinal OTC Drugs Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Revenue and Growth Rate (2012-2017)
Table Europe Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2012-2017)
Table Europe Gastrointestinal OTC Drugs Market Share by Type (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Market Share by Type in 2016
Table Europe Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2012-2017)
Table Europe Gastrointestinal OTC Drugs Market Share by Application (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Market Share by Application in 2016
Table Europe Gastrointestinal OTC Drugs Sales (K Pcs) by Countries (2012-2017)
Table Europe Gastrointestinal OTC Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Sales Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Sales Market Share by Countries in 2016
Table Europe Gastrointestinal OTC Drugs Revenue (Million USD) by Countries (2012-2017)
Table Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Europe Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2016
Figure Germany Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Market Share by Type (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Market Share by Type (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Sales (K Pcs) by Applications (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Market Share by Applications (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Sales Market Share by Application in 2016
Table Middle East Gastrointestinal OTC Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Sales Volume Market Share by Countries in 2016
Table Middle East Gastrointestinal OTC Drugs Revenue (Million USD) by Countries (2012-2017)
Table Middle East Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Middle East Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2016
Figure Saudi Arabia Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Gastrointestinal OTC Drugs Sales (K Pcs) by Type (2012-2017)
Table Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share by Type (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share by Type in 2016
Table Africa Gastrointestinal OTC Drugs Sales (K Pcs) by Application (2012-2017)
Table Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share by Application (2012-2017)
Table Africa Gastrointestinal OTC Drugs Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Gastrointestinal OTC Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share by Countries in 2016
Table Africa Gastrointestinal OTC Drugs Revenue (Million USD) by Countries (2012-2017)
Table Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries (2012-2017)
Figure Africa Gastrointestinal OTC Drugs Revenue Market Share by Countries in 2016
Figure South Africa Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Table Bayer Gastrointestinal OTC Drugs Basic Information List
Table Bayer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Bayer Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Gastrointestinal OTC Drugs Basic Information List
Table GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Gastrointestinal OTC Drugs Basic Information List
Table Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Pfizer Gastrointestinal OTC Drugs Basic Information List
Table Pfizer Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Pfizer Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Perrigo Gastrointestinal OTC Drugs Basic Information List
Table Perrigo Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Perrigo Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Abbott Gastrointestinal OTC Drugs Basic Information List
Table Abbott Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Abbott Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table C.B. Fleet Gastrointestinal OTC Drugs Basic Information List
Table C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure C.B. Fleet Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Purdue Pharma Gastrointestinal OTC Drugs Basic Information List
Table Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Purdue Pharma Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Basic Information List
Table Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Teva Pharmaceutical Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Sanofi Gastrointestinal OTC Drugs Basic Information List
Table Sanofi Gastrointestinal OTC Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Sales Market Share in EMEA (2012-2017)
Figure Sanofi Gastrointestinal OTC Drugs Revenue Market Share in EMEA (2012-2017)
Table Boehringer Ingelheim Gastrointestinal OTC Drugs Basic Information List
Table Xiuzheng Pharmaceutical Group Gastrointestinal OTC Drugs Basic Information List
Table China Resources Sanjiu Medical & Pharmaceutical Gastrointestinal OTC Drugs Basic Information List
Table Harbin Pharmaceutical Group Gastrointestinal OTC Drugs Basic Information List
Table JZJT Gastrointestinal OTC Drugs Basic Information List
Table Tongrentang (TRT) Gastrointestinal OTC Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Gastrointestinal OTC Drugs
Figure Manufacturing Process Analysis of Gastrointestinal OTC Drugs
Figure Gastrointestinal OTC Drugs Industrial Chain Analysis
Table Raw Materials Sources of Gastrointestinal OTC Drugs Major Manufacturers in 2016
Table Major Buyers of Gastrointestinal OTC Drugs
Table Distributors/Traders List
Figure EMEA Gastrointestinal OTC Drugs Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share Forecast by Region (2017-2022)
Table EMEA Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Revenue Market Share Forecast by Region (2017-2022)
Table Europe Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal OTC Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Europe Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Gastrointestinal OTC Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal OTC Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Gastrointestinal OTC Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal OTC Drugs Sales Market Share Forecast by Countries (2017-2022)
Table Africa Gastrointestinal OTC Drugs Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Gastrointestinal OTC Drugs Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share Forecast by Type (2017-2022)
Table EMEA Gastrointestinal OTC Drugs Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Gastrointestinal OTC Drugs Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
